David C. Marek
Chief Executive Officer bei MYOVANT SCIENCES LTD.
Profil
David C.
Marek is currently the Chief Executive Officer at Myovant Sciences Ltd.
He previously served as the Chief Executive Officer & Director at Myovant Sciences, Inc. from 2021 to 2023.
Prior to that, he was the Managing Director at Saatchi & Saatchi Healthcare Advertising from 2000 to 2011.
He also held the position of Vice President & General Manager-Neuroscience at Amgen, Inc. from 2017 to 2019.
In addition, he served as the EVP-Consumer Services & Commercial Strategy at WebMD Health Corp.
from 2012 to 2014 and as the Chief Commercial Officer at Axsome Therapeutics, Inc. from 2019 to 2020.
Mr. Marek completed his undergraduate degree at Washington State University.
Aktive Positionen von David C. Marek
| Unternehmen | Position | Beginn |
|---|---|---|
| MYOVANT SCIENCES LTD. | Chief Executive Officer | 04.01.2021 |
Ehemalige bekannte Positionen von David C. Marek
| Unternehmen | Position | Ende |
|---|---|---|
Myovant Sciences, Inc.
 Myovant Sciences, Inc. Medical SpecialtiesHealth Technology Myovant Sciences, Inc. offers therapeutics for women's health and prostate cancer. The company is headquartered in New York, NY. | Chief Executive Officer | 01.06.2023 |
| AXSOME THERAPEUTICS, INC. | Corporate Officer/Principal | 31.12.2020 |
| AMGEN INC. | Corporate Officer/Principal | 01.06.2019 |
| WEBMD HEALTH CORP. | Corporate Officer/Principal | 01.01.2014 |
Saatchi & Saatchi Healthcare Advertising
 Saatchi & Saatchi Healthcare Advertising Advertising/Marketing ServicesCommercial Services Part of Publicis Healthcare Communications Group, Inc., Saatchi & Saatchi Healthcare Advertising provides advertising services. | Corporate Officer/Principal | 01.01.2011 |
Ausbildung von David C. Marek
| Washington State University | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| AMGEN INC. | Health Technology |
| AXSOME THERAPEUTICS, INC. | Health Technology |
| Private Unternehmen | 4 |
|---|---|
WebMD Health Corp.
 WebMD Health Corp. Internet Software/ServicesTechnology Services WebMD Health Corp. engages in the provision of health information services. It serves physicians, health care professionals, employers, and health plans through public and private online portals, mobile platforms, and health-focused publications. The company is headquartered in New York, NY. | Technology Services |
Saatchi & Saatchi Healthcare Advertising
Saatchi & Saatchi Healthcare Advertising Advertising/Marketing ServicesCommercial Services Part of Publicis Healthcare Communications Group, Inc., Saatchi & Saatchi Healthcare Advertising provides advertising services. | Commercial Services |
Myovant Sciences, Inc.
Myovant Sciences, Inc. Medical SpecialtiesHealth Technology Myovant Sciences, Inc. offers therapeutics for women's health and prostate cancer. The company is headquartered in New York, NY. | Health Technology |
Myovant Sciences Ltd.
 Myovant Sciences Ltd. BiotechnologyHealth Technology Myovant Sciences Ltd. is a clinical-stage biopharmaceutical company, which engages in the development and commercialization of therapies for the treatment of women's health and endocrine diseases. It offers ORGOVYXTM, an oral gonadotropin-releasing hormone (GnRH) receptor antagonist for the treatment of adult patients with advanced prostate cancer, and MYFEMBREE, which is taken for the management of heavy menstrual bleeding associated with uterine fibroids. The company was founded on February 2, 2016 and is headquartered in London, the United Kingdom. | Health Technology |
